Is REVE or JNJ a better dividend investment in 2026?

REVE currently yields 18.98% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: REVE offers higher current income.

What is the dividend yield difference between REVE and JNJ?

REVE has a forward dividend yield of 18.98% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 15.62 percentage points.

Home › Compare › REVE vs JNJ

REVE vs JNJ: Dividend Comparison 2026

REVE yields 18.98% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 REVE wins by $48.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

REVE

● Live price

18.98%

Share price

$10.54

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$68.6K

Annual income

$6,031.52

Full REVE calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — REVE vs JNJ

📍 REVE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	REVE	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, REVE + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

REVE pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REVE

Annual income on $10K today (after 15% tax)

$1,612.90/yr

After 10yr DRIP, annual income (after tax)

$5,126.79/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, REVE beats the other by $4,423.18/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REVE + JNJ for your $10,000?

REVE: 50%JNJ: 50%

100% JNJ50/50100% REVE

Portfolio after 10yr

$44.3K

Annual income

$3,429.65/yr

Blended yield

7.74%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

REVE

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REVE buys

JNJ buys

No recent congressional trades found for REVE or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricREVEJNJ

Forward yield	18.98% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$68.6K ✓	$20.0K
Annual income after 10y	$6,031.52 ✓	$827.78
Total dividends collected	$37.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: REVE vs JNJ ($10,000, DRIP)

Year	REVE Portfolio	REVE Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,598	$1,897.53	$10,676	$355.77	+$1.9K → REVE
2	$15,713	$2,234.04	$11,407	$389.39	+$4.3K → REVE
3	$19,418	$2,604.31	$12,198	$426.53	+$7.2K → REVE
4	$23,785	$3,007.70	$13,056	$467.62	+$10.7K → REVE
5	$28,893	$3,443.10	$13,987	$513.12	+$14.9K → REVE
6	$34,824	$3,908.92	$14,998	$563.56	+$19.8K → REVE
7	$41,665	$4,403.17	$16,098	$619.52	+$25.6K → REVE
8	$49,505	$4,923.49	$17,295	$681.69	+$32.2K → REVE
9	$58,437	$5,467.23	$18,599	$750.82	+$39.8K → REVE
10	$68,560	$6,031.52	$20,022	$827.78	+$48.5K → REVE

REVE vs JNJ: Complete Analysis 2026

REVE — Stock

Alpine Acquisition Corporation does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more target businesses. It intends to focus its search on drive-to destination hotels, digital entertainment and gaming, and lodging technology businesses. The company was incorporated in 2021 and is based in Fountain Hills, Arizona.

Full REVE Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this REVE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REVE vs SCHD REVE vs JEPI REVE vs O REVE vs KO REVE vs MAIN REVE vs ABBV REVE vs MRK REVE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.